WASHINGTON (AP) - Federal investigators have found “reasonable grounds” that a government whistleblower was punished for opposing widespread use of an unproven drug that President Donald Trump touted as a remedy for COVID-19, his lawyers said Friday. RELATED:Fired scientist claims Trump administration rejected his early warnings on COVID-19 Dr.
Rick Bright headed the Biomedical Advanced Research and Development Authority. He had received a job performance review of outstanding before he was summarily transferred last month.
The agency is a unit of the Department of Health and Human Services. FILE - An image of Hydroxychloroquine, a medication touted by Trump as being a treatment for coronavirus. (Photo by Óscar J.